Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Potassium chloride + sodium lactate + sodium chloride + calcium chloride + dextrose** is a fixed-combination intravenous crystalloid solution marketed as **Lactated Ringers and Dextrose** and **Potassium Chloride in Lactated Ringers and Dextrose**. It is a pharmaceutical multi-electrolyte and carbohydrate parenteral fluid composed of inorganic salts plus dextrose, developed and marketed by Hospira. The product is used as a source of water, electrolytes, and calories, for parenteral replacement of extracellular fluid and electrolyte losses, and as an alkalinizing agent. Its pharmacologic effect is supportive rather than receptor-targeted: sodium, potassium, calcium, chloride, and lactate help restore fluid and electrolyte balance, while dextrose provides carbohydrate calories; lactate is metabolized to bicarbonate precursors and contributes an alkalinizing effect. It is supplied as a single-dose intravenous injection or infusion solution for adult and pediatric use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium chloride + sodium lactate + sodium chloride + calcium chloride + dextrose.